A Phase II Proof of Concept (PoC), Double-Blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VSN16R for the Treatment of Spasticity in Subjects With Multiple Sclerosis
Phase II a Proof of concept study in Multiple Sclerosis (MS) patients with spasticity.
100 Clinical Results associated with Canbex Therapeutics Ltd.
0 Patents (Medical) associated with Canbex Therapeutics Ltd.
100 Deals associated with Canbex Therapeutics Ltd.
100 Translational Medicine associated with Canbex Therapeutics Ltd.